开发了12个基质的短二元神经遗传性寡度氧核化物,可诱导神经特异化
Koji Umezawa1,2, Rena Ikeda3, Taiichi Sakamoto4
1Department of Agricultural and Life Sciences, Faculty of Agriculture, Shinshu University, 8304 Minami-minowa, Kami-ina 399-4598, Japan.
Biotech (Basel (Switzerland))
|May 28, 2024
概括
一种新的,较短的DNA药物 (iMyo01) 有效地促进肌肉分化,为肌肉消耗疾病的现有治疗提供了更具成本效益的替代方案. 这种神经遗传性寡氧化核酸 (myoDN) 通过独特的G-四重复结构来维持治疗功能.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 像iSN04这样的肌源性寡氧核化物 (myoDNs) 通过诱导肌源性差异化来治疗肌肉损耗有前途.
- 目前的myoDN在药物疗效和合成成本方面面临挑战,需要序列优化.
研究的目的:
- 开发一种更短,更具成本效益的myoDN,并保持肌性活性.
- 调查截断的myoDNs的功能结构基础.
主要方法:
- 一种新型的12基 myoDN (iMyo01) 的合成和特征.
- 在初级人类肌细胞质中测试肌原性活性.
- 核林结合性研究.
- 核磁共振 (NMR) 和原生聚烯胺凝电泳 (PAGE).
- 计算分子动力学模拟.
主要成果:
- 12 基的 iMyo01 显示出与 18 基 iSN04 具有相似的肌性活性.
- 无论是iMyo01还是iSN04,都与核素相互作用,并提高了肌性基因表达的调节.
- 尽管iMyo01的序列短,非端粒序列,但它形成了一个稳定的G-四重复结构,可能是同位体.
- 与iSN04不同,iMyo01没有与柏柏林结合.
结论:
- 阿普塔默切割技术可以产生更短,生物活性的核酸药物.
- iMyo01代表了一个有希望的,优化的myoDN,用于肌肉消耗疾病的潜在治疗应用.
- 由iMyo01形成的G-四重体结构是其保存生物活性的关键.
相关概念视频
Formation of Muscle Fibers from Myoblasts
4.9K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.9K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


